131 related articles for article (PubMed ID: 12079492)
1. 3rd international symposium on genetic anticancer agents.
Wysocki PJ; Mackiewicz-Wysocka M
Expert Opin Biol Ther; 2002 Jun; 2(5):565-8. PubMed ID: 12079492
[TBL] [Abstract][Full Text] [Related]
2. Getting oncolytic virus therapies off the ground.
Bell JC; Lichty B; Stojdl D
Cancer Cell; 2003 Jul; 4(1):7-11. PubMed ID: 12892708
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy out of the gate: the 22nd annual Cancer Research Institute International Immunotherapy Symposium.
Tontonoz M; Gee CE
Cancer Immunol Res; 2015 May; 3(5):444-8. PubMed ID: 25941356
[TBL] [Abstract][Full Text] [Related]
4. Highlights of the Second International Symposium on Genetic Anticancer Agents.
Gerritsen WR; Krul MR
Cancer Gene Ther; 2001 Sep; 8(9):678-80. PubMed ID: 11593338
[No Abstract] [Full Text] [Related]
5. Progress in cancer gene therapy.
Curiel DT; Gerritsen WR; Krul MR
Cancer Gene Ther; 2000 Aug; 7(8):1197-9. PubMed ID: 10975681
[TBL] [Abstract][Full Text] [Related]
6. Biological Therapy of Cancer--From Basic Research to Clinical Application, the 3rd International Symposium. Munich, Germany, April 1995. Abstracts.
Eur J Cancer; 1995; 31A Suppl 3():S1-38. PubMed ID: 8554916
[No Abstract] [Full Text] [Related]
7. Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).
Deola S; Guerrouahen BS; Sidahmed H; Al-Mohannadi A; Elnaggar M; Elsadig R; Abdelalim EM; Petrovski G; Gadina M; Thrasher A; Wels WS; Hunger SP; Wang E; Marincola FM; ; Maccalli C; Cugno C
J Transl Med; 2018 Oct; 16(1):276. PubMed ID: 30305089
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005.
Britten CM; Gouttefangeas C; Kreiter S
Cancer Immunol Immunother; 2006 Apr; 55(4):475-80. PubMed ID: 16193336
[TBL] [Abstract][Full Text] [Related]
9. 21st International Congress on Anticancer Treatment.
Magné N; Pacaut C; Chargari C
Expert Rev Anticancer Ther; 2010 May; 10(5):647-9. PubMed ID: 20469995
[TBL] [Abstract][Full Text] [Related]
10. International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?
Belardelli F; Ferrantini M; Parmiani G; Schlom J; Garaci E
Cancer Res; 2004 Sep; 64(18):6827-30. PubMed ID: 15375003
[TBL] [Abstract][Full Text] [Related]
11. Congress Report: XIX symposium of the International Association for Comparative Research on Leukemia and Related Diseases, Mannheim/Heidelberg, Germany, July 13 - 18, 1997.
Hochhaus A; Berger U; Krämer A; Reiter A; Seifarth W; Willer A; Hehlmann R
Eur J Med Res; 1998 Apr; 3(4):216-22. PubMed ID: 9533931
[TBL] [Abstract][Full Text] [Related]
12. 10th International Conference on gene therapy of cancer: 13 - 15 December 2001, San Diego, CA, USA.
Chen Y
Expert Opin Biol Ther; 2002 Apr; 2(4):443-5. PubMed ID: 11955281
[TBL] [Abstract][Full Text] [Related]
13. Cellular therapy of cancer symposium December 2nd-3rd 2006 Manchester, UK.
Thistlethwaite FC; Gilham DE; Hawkins RE
Cancer Immunol Immunother; 2007 Jun; 56(6):939-42. PubMed ID: 17333180
[No Abstract] [Full Text] [Related]
14. International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers.
Guinn BA; Norris JS; Huang L; Farzaneh F; Kasahara N; Deisseroth AB
Cancer Immunol Immunother; 2006 Nov; 55(11):1406-11. PubMed ID: 16783577
[No Abstract] [Full Text] [Related]
15. Routing cancer immunology and immunotherapy from the lab to the clinic 4-5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain.
Aznar MÁ; Melero I; Quetglas JI
J Transl Med; 2014 Jul; 12():202. PubMed ID: 25060862
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus vectors: potential applications for cancer gene therapy.
Li C; Bowles DE; van Dyke T; Samulski RJ
Cancer Gene Ther; 2005 Dec; 12(12):913-25. PubMed ID: 15962012
[TBL] [Abstract][Full Text] [Related]
17. Meeting report on the second targeted tumor therapies.
Bachran C; Fuchs H
Mol Cancer Ther; 2010 Jan; 9(1):17-23. PubMed ID: 20053770
[TBL] [Abstract][Full Text] [Related]
18. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
19. British Cancer Research Meeting, 30 June-3 July 2002, Glasgow.
Parkes AT; Speirs V
Breast Cancer Res; 2002; 4(5):202-4. PubMed ID: 12223125
[TBL] [Abstract][Full Text] [Related]
20. Development of Gene Therapeutics for Head and Neck Cancer in China: From Bench to Bedside.
Guo W; Song H
Hum Gene Ther; 2018 Feb; 29(2):180-187. PubMed ID: 29334764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
